Home NDC 73279-0004-2 Toplast Pain Relief Lidocaine 4percent plus Menthol 1percent
Product NDC 73279-0004
Requested package NDC 73279-0004-2
11-digit product format 732790004
Labeler code 73279
Product ID 73279-0004_bebd9d71-2689-4dfb-a276-e6f5b8153d80
Type HUMAN OTC DRUG
Nonproprietary name Lidocaine, Menthol
Dosage form PATCH
Route TOPICAL
Labeler Icure Pharmaceutical Inc, Wanju Factory
Application part348
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2020-07-01
Marketing end 0000-00-00
Substance LIDOCAINE; MENTHOL
Active strength 240 mg/1; mg/1
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 16 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 fb8cb913e6d1…eb8c232b6be0…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73279-0004-1 Toplast Pain Relief Lidocaine 4percent plus Menthol 1percent 1 in 1 POUCH PATCH 1 3 73279-0004-2 Toplast Pain Relief Lidocaine 4percent plus Menthol 1percent 5 in 1 CARTON PATCH 5 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 73279-0004 TOPLAST PAIN RELIEF LIDOCAINE 4PERCENT PLUS MENTHOL 1PERCENT (LIDOCAINE, MENTHOL) PATCH [ICURE PHARMACEUTICAL INC, WANJU FACTORY] 3 Legacy NDC, 2 package rows 20210424_d5e31458-1d86-4064-bdbd-8a2782c621aa.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 73279-0004-2 73279000402 5 POUCH in 1 CARTON (73279-0004-2) > 1 PATCH in 1 POUCH (73279-0004-1) 5 pouch 2020-07-01 0000-00-00 No No Current